Press Release

Category Added in a WPeMatico Campaign

Cision PR Newswire21 April 2026

Drug Hunter Launches Molecule Search: A Unified Structure Search Experience Across Chemical and Biological Data

SAN FRANCISCO and PORTLAND, Ore. and BOSTON, April 21, 2026 /PRNewswire/ — Drug Hunter, the intelligence platform for drug discovery teams,…
Read More »
Cision PR Newswire21 April 2026

Ellucian Announces 2026 Experience Idol Winners Celebrating Innovation and Excellence in Higher Education

Key Highlights: Six winners — three higher education institutions and three partners — recognized for innovative use of the Ellucian…
Read More »
Cision PR Newswire21 April 2026

PaleBlueDot AI Launches PBD TokenRouter, a Unified Platform for Accessing AI Models

Company also unveils premium credit program for builders, startups, and enterprises to accelerate growth PALO ALTO, Calif., April 21, 2026…
Read More »
Cision PR Newswire21 April 2026

Boards Need a New Playbook for Oversight of Strategy Execution, NACD Finds

NACD’s 2026 Blue Ribbon Commission will define how boards can better oversee strategy execution amid rising complexity and disruption. WASHINGTON,…
Read More »
MarketersMEDIA Newswire21 April 2026

AUTOMATIC Releases New Report on Agentic AI Adoption in Finance & Business Services

Research highlights rapid growth of autonomous AI systems and their impact on financial operations, compliance, and enterprise workflows Bentonville, Arkansas,…
Read More »
Business Wire21 April 2026

ITA Group Deepens Support of Ownership Works Through Premier Sponsorship of CEO & Executive Convening

WEST DES MOINES, Iowa–(BUSINESS WIRE)–ITA Group, a 100% employee-owned global engagement agency, has been named a Premier Sponsor of the…
Read More »
Business Wire21 April 2026

Wenger and Extru-Tech Unite Under JBT Marel at Petfood Forum 2026

Combined Brands Expand Capabilities; Unveil New Minimally Processed Pet Food Lines KANSAS CITY, Mo.–(BUSINESS WIRE)–Wenger and Extru-Tech, both global leaders…
Read More »
Business Wire21 April 2026

Corcept to Present New Data from Pivotal Phase 3 ROSELLA Trial of Lifyorli™ (Relacorilant) in Patients with Platinum-Resistant Ovarian Cancer at ASCO 2026

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to…
Read More »
Business Wire21 April 2026

Corcept to Present New Data from Pivotal Phase 3 ROSELLA Trial of Lifyorli™ (Relacorilant) in Patients with Platinum-Resistant Ovarian Cancer at ASCO 2026

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to…
Read More »
Business Wire21 April 2026

Corcept to Present New Data from Pivotal Phase 3 ROSELLA Trial of Lifyorli™ (Relacorilant) in Patients with Platinum-Resistant Ovarian Cancer at ASCO 2026

REDWOOD CITY, Calif.–(BUSINESS WIRE)–Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to…
Read More »

Previous page Next page